Marsh & McLennan stock holds steady on insurance and consulting scale

Marsh & McLennan (ISIN US5717481023) is a large-cap US services company whose revenue base comes from insurance brokerage, risk management, consulting, and employee benefits advisory.

Its shares trade on the New York Stock Exchange under MMC, and the company remains tied to broad corporate spending on risk transfer and advisory services across the US market.

Business breadth matters

The company operates through Marsh, Guy Carpenter, Mercer, and Oliver Wyman, giving it exposure to insurance placement, reinsurance brokerage, human capital, and management consulting. That mix matters because it reduces dependence on any single product line and links results to recurring corporate demand rather than one-off transactions.

For investors, the key structural point is scale: Marsh & McLennan sits among the largest global brokers and advisory groups, which tends to support pricing power and client retention over time.

US market anchor

MMC is listed on the NYSE, which gives the stock a direct US-market reference point alongside broad institutional ownership. In that setting, the company is often read as a barometer for commercial insurance pricing and enterprise risk spending.

The stock also sits inside a well-known US large-cap universe, so relative performance is usually judged against other financial and services names rather than against high-beta growth shares.

Insurance brokerage

Marsh is the company's flagship insurance brokerage business, helping clients place coverage and manage complex risk programs.

That business is the clearest product-level expression of the group's model: it earns fees from ongoing client relationships rather than from a single sale.

Shares and valuation

Marsh & McLennan stock is trading in New York at $0.00 USD as of July 15, 2026, 2:47 a.m. ET.